Barclays PLC Soma Logic, Inc. Transaction History

Barclays PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$1.76 - $2.83 $262,470 - $422,040	149,131 Added 5.74%	2,745,920 $6.95 Million
Q3 2023 Nov 07, 2023	BUY	$1.99 - $2.45 $41,497 - $51,089	20,853 Added 0.81%	2,596,789 $6.21 Million
Q2 2023 Aug 03, 2023	SELL	$2.1 - $3.36 $68,554 - $109,687	-32,645 Reduced 1.25%	2,575,936 $5.95 Million
Q1 2023 May 04, 2023	BUY	$2.13 - $3.6 $209,425 - $353,959	98,322 Added 3.92%	2,608,581 $6.65 Million
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $5.1 Million - $8.63 Million	2,485,878 Added 10195.96%	2,510,259 $6.3 Million
Q3 2022 Nov 03, 2022	SELL	$0.63 - $5.47 $382,451 - $3.32 Million	-607,066 Reduced 96.14%	24,381 $70,000
Q2 2022 Aug 12, 2022	BUY	$4.27 - $8.26 $2.69 Million - $5.21 Million	630,778 Added 94286.7%	631,447 $2.85 Million
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $4,729 - $7,773	669 New	669 $5,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.